Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arrhythmogenic Right Ventricular Dysplasia | 6 | 2022 | 162 | 2.230 |
Why?
|
Arrhythmias, Cardiac | 17 | 2024 | 2246 | 2.020 |
Why?
|
Long QT Syndrome | 11 | 2024 | 467 | 1.930 |
Why?
|
Tachycardia, Ventricular | 11 | 2024 | 1304 | 1.850 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 2 | 2023 | 182 | 1.580 |
Why?
|
Catheter Ablation | 26 | 2022 | 2752 | 1.540 |
Why?
|
Accessory Atrioventricular Bundle | 5 | 2023 | 58 | 1.400 |
Why?
|
Electrocardiography | 24 | 2023 | 6384 | 1.360 |
Why?
|
Heart Conduction System | 9 | 2019 | 1010 | 1.250 |
Why?
|
Ebstein Anomaly | 3 | 2021 | 105 | 1.080 |
Why?
|
Wolff-Parkinson-White Syndrome | 3 | 2023 | 116 | 1.030 |
Why?
|
Death, Sudden, Cardiac | 12 | 2024 | 1555 | 1.010 |
Why?
|
Pre-Excitation Syndromes | 2 | 2023 | 27 | 0.990 |
Why?
|
Body Surface Potential Mapping | 5 | 2019 | 228 | 0.870 |
Why?
|
Ventricular Premature Complexes | 1 | 2024 | 112 | 0.840 |
Why?
|
Plakophilins | 1 | 2022 | 32 | 0.810 |
Why?
|
Cardiomyopathy, Hypertrophic | 4 | 2024 | 1313 | 0.800 |
Why?
|
Desmoplakins | 5 | 2024 | 61 | 0.770 |
Why?
|
Heart Defects, Congenital | 8 | 2022 | 4696 | 0.700 |
Why?
|
Stillbirth | 2 | 2020 | 368 | 0.700 |
Why?
|
Nadolol | 2 | 2023 | 29 | 0.690 |
Why?
|
Ventricular Dysfunction, Left | 5 | 2024 | 2119 | 0.620 |
Why?
|
Ventricular Fibrillation | 1 | 2020 | 537 | 0.570 |
Why?
|
Metabolic Diseases | 1 | 2023 | 681 | 0.560 |
Why?
|
Electrophysiologic Techniques, Cardiac | 7 | 2020 | 506 | 0.550 |
Why?
|
Tachycardia, Supraventricular | 4 | 2021 | 273 | 0.540 |
Why?
|
Atrial Fibrillation | 12 | 2023 | 5127 | 0.540 |
Why?
|
Health Services Administration | 1 | 2017 | 63 | 0.530 |
Why?
|
Fontan Procedure | 4 | 2013 | 797 | 0.530 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 3 | 2022 | 148 | 0.520 |
Why?
|
Heart Rate | 6 | 2020 | 4198 | 0.510 |
Why?
|
Heart Bypass, Right | 1 | 2015 | 75 | 0.480 |
Why?
|
Cardiomyopathies | 2 | 2024 | 1964 | 0.470 |
Why?
|
Defibrillators, Implantable | 7 | 2021 | 1490 | 0.450 |
Why?
|
Heart Atria | 6 | 2016 | 1347 | 0.440 |
Why?
|
Genetic Testing | 7 | 2022 | 3538 | 0.440 |
Why?
|
Exercise Test | 2 | 2020 | 2129 | 0.430 |
Why?
|
Myocytes, Cardiac | 4 | 2024 | 1668 | 0.420 |
Why?
|
Brugada Syndrome | 2 | 2018 | 93 | 0.410 |
Why?
|
Autopsy | 1 | 2016 | 1007 | 0.410 |
Why?
|
Projection | 1 | 2011 | 18 | 0.390 |
Why?
|
Heart Arrest | 3 | 2020 | 1514 | 0.380 |
Why?
|
Syncope | 3 | 2019 | 427 | 0.380 |
Why?
|
Disease Management | 3 | 2017 | 2507 | 0.380 |
Why?
|
Sports | 1 | 2017 | 705 | 0.380 |
Why?
|
Defense Mechanisms | 1 | 2011 | 180 | 0.370 |
Why?
|
Family | 3 | 2022 | 3197 | 0.360 |
Why?
|
Child | 38 | 2024 | 80162 | 0.360 |
Why?
|
Social Identification | 1 | 2011 | 108 | 0.360 |
Why?
|
Forecasting | 1 | 2019 | 2928 | 0.360 |
Why?
|
Emotional Intelligence | 1 | 2011 | 135 | 0.350 |
Why?
|
Electrocardiography, Ambulatory | 3 | 2020 | 578 | 0.340 |
Why?
|
Theory of Mind | 1 | 2011 | 91 | 0.340 |
Why?
|
Transposition of Great Vessels | 3 | 2022 | 594 | 0.340 |
Why?
|
Adolescent | 35 | 2024 | 88313 | 0.320 |
Why?
|
Angina Pectoris | 1 | 2012 | 959 | 0.310 |
Why?
|
Channelopathies | 2 | 2018 | 30 | 0.300 |
Why?
|
Activities of Daily Living | 1 | 2017 | 2421 | 0.300 |
Why?
|
Humans | 97 | 2024 | 761423 | 0.290 |
Why?
|
Prejudice | 1 | 2011 | 570 | 0.280 |
Why?
|
Atrioventricular Block | 2 | 2022 | 133 | 0.270 |
Why?
|
Survivors | 1 | 2017 | 2371 | 0.260 |
Why?
|
Endocardium | 1 | 2007 | 248 | 0.260 |
Why?
|
Circadian Rhythm | 1 | 2017 | 2574 | 0.260 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2009 | 710 | 0.260 |
Why?
|
Chordae Tendineae | 1 | 2005 | 39 | 0.250 |
Why?
|
Sympathectomy | 2 | 2016 | 72 | 0.250 |
Why?
|
Truncus Arteriosus, Persistent | 1 | 2005 | 63 | 0.250 |
Why?
|
Child, Preschool | 19 | 2024 | 42254 | 0.250 |
Why?
|
Tachycardia | 3 | 2013 | 600 | 0.240 |
Why?
|
Syndactyly | 1 | 2024 | 74 | 0.230 |
Why?
|
Female | 61 | 2024 | 392581 | 0.230 |
Why?
|
Cardiac Myosins | 1 | 2024 | 128 | 0.230 |
Why?
|
Tricuspid Valve Insufficiency | 2 | 2005 | 355 | 0.230 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2023 | 1241 | 0.230 |
Why?
|
Electrophysiology | 1 | 2007 | 1262 | 0.230 |
Why?
|
Male | 58 | 2024 | 360736 | 0.220 |
Why?
|
Calmodulin | 1 | 2024 | 218 | 0.220 |
Why?
|
Genetic Variation | 1 | 2019 | 6581 | 0.220 |
Why?
|
Electric Countershock | 3 | 2020 | 533 | 0.220 |
Why?
|
Calcium Channels, L-Type | 1 | 2024 | 242 | 0.210 |
Why?
|
Flecainide | 1 | 2023 | 41 | 0.210 |
Why?
|
Heart Septum | 2 | 2024 | 303 | 0.210 |
Why?
|
Myosin Heavy Chains | 1 | 2024 | 405 | 0.210 |
Why?
|
Heart Failure | 5 | 2024 | 11674 | 0.210 |
Why?
|
Retrospective Studies | 23 | 2024 | 80582 | 0.200 |
Why?
|
Diagnostic Errors | 1 | 2010 | 1265 | 0.200 |
Why?
|
Tricuspid Valve | 1 | 2005 | 413 | 0.200 |
Why?
|
Ciliary Motility Disorders | 1 | 2022 | 51 | 0.200 |
Why?
|
Consensus | 4 | 2020 | 3122 | 0.200 |
Why?
|
KCNQ1 Potassium Channel | 2 | 2019 | 102 | 0.200 |
Why?
|
Pulmonary Atresia | 1 | 2003 | 159 | 0.200 |
Why?
|
Oligonucleotides, Antisense | 1 | 2024 | 461 | 0.190 |
Why?
|
Cicatrix | 1 | 2007 | 798 | 0.180 |
Why?
|
Cardiology | 3 | 2018 | 1667 | 0.180 |
Why?
|
Infant | 13 | 2024 | 36205 | 0.180 |
Why?
|
Calsequestrin | 1 | 2020 | 30 | 0.180 |
Why?
|
Young Adult | 16 | 2024 | 59207 | 0.180 |
Why?
|
Phenotype | 5 | 2024 | 16606 | 0.180 |
Why?
|
Sotalol | 1 | 2020 | 47 | 0.170 |
Why?
|
Disease Progression | 2 | 2015 | 13502 | 0.170 |
Why?
|
Heart Block | 2 | 2019 | 392 | 0.170 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2020 | 141 | 0.160 |
Why?
|
Registries | 4 | 2024 | 8223 | 0.160 |
Why?
|
Imaging, Three-Dimensional | 3 | 2007 | 4063 | 0.160 |
Why?
|
Pulmonary Valve | 1 | 2003 | 412 | 0.160 |
Why?
|
Cardiac Resynchronization Therapy | 3 | 2018 | 555 | 0.160 |
Why?
|
Action Potentials | 4 | 2024 | 1834 | 0.160 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2024 | 829 | 0.160 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2019 | 174 | 0.160 |
Why?
|
Equipment Failure Analysis | 1 | 2021 | 847 | 0.150 |
Why?
|
Echocardiography | 7 | 2018 | 4991 | 0.150 |
Why?
|
Mutation, Missense | 2 | 2020 | 2571 | 0.150 |
Why?
|
Penetrance | 1 | 2020 | 388 | 0.150 |
Why?
|
Genes, Dominant | 1 | 2020 | 863 | 0.150 |
Why?
|
Recurrence | 7 | 2022 | 8469 | 0.150 |
Why?
|
Catheterization | 1 | 2003 | 1432 | 0.150 |
Why?
|
Heterozygote | 2 | 2024 | 2803 | 0.150 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2012 | 866 | 0.140 |
Why?
|
Supine Position | 1 | 2017 | 205 | 0.140 |
Why?
|
Genetics, Population | 1 | 2022 | 939 | 0.140 |
Why?
|
Risk Factors | 16 | 2024 | 74167 | 0.140 |
Why?
|
Pulmonary Artery | 1 | 2005 | 1938 | 0.140 |
Why?
|
Treatment Outcome | 19 | 2024 | 64651 | 0.140 |
Why?
|
Catecholamines | 1 | 2017 | 386 | 0.140 |
Why?
|
Electrodes, Implanted | 1 | 2021 | 840 | 0.130 |
Why?
|
Cardiac Electrophysiology | 1 | 2016 | 59 | 0.130 |
Why?
|
Adult | 24 | 2024 | 221148 | 0.130 |
Why?
|
Cardiovascular Diseases | 2 | 2019 | 15498 | 0.130 |
Why?
|
Bundle-Branch Block | 1 | 2018 | 278 | 0.130 |
Why?
|
Follow-Up Studies | 12 | 2024 | 39117 | 0.130 |
Why?
|
Heart Diseases | 2 | 2022 | 2785 | 0.130 |
Why?
|
Homozygote | 1 | 2020 | 1796 | 0.130 |
Why?
|
Predictive Value of Tests | 6 | 2020 | 15262 | 0.130 |
Why?
|
Patient Care Management | 1 | 2018 | 302 | 0.120 |
Why?
|
Causality | 1 | 2020 | 1243 | 0.120 |
Why?
|
Cardiac Surgical Procedures | 4 | 2021 | 3630 | 0.120 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 2014 | 72 | 0.120 |
Why?
|
Mutation | 6 | 2024 | 30045 | 0.110 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2020 | 773 | 0.110 |
Why?
|
Infant, Newborn | 7 | 2024 | 26212 | 0.110 |
Why?
|
Stents | 1 | 2005 | 3179 | 0.110 |
Why?
|
Age Factors | 5 | 2019 | 18400 | 0.110 |
Why?
|
Muscle Proteins | 1 | 2019 | 1154 | 0.110 |
Why?
|
Posture | 1 | 2017 | 956 | 0.110 |
Why?
|
Stroke Volume | 2 | 2024 | 5497 | 0.110 |
Why?
|
Heart Transplantation | 2 | 2024 | 3234 | 0.100 |
Why?
|
Surgery, Computer-Assisted | 2 | 2013 | 1007 | 0.100 |
Why?
|
Time Factors | 8 | 2024 | 39975 | 0.100 |
Why?
|
Desmosomes | 1 | 2012 | 72 | 0.100 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2013 | 189 | 0.100 |
Why?
|
Exercise | 3 | 2024 | 5884 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2024 | 1860 | 0.100 |
Why?
|
Warfarin | 2 | 2010 | 1483 | 0.100 |
Why?
|
Pulmonary Veins | 2 | 2007 | 746 | 0.090 |
Why?
|
Myocardial Infarction | 1 | 2012 | 11458 | 0.090 |
Why?
|
American Heart Association | 1 | 2016 | 1045 | 0.090 |
Why?
|
Keratinocytes | 2 | 2012 | 790 | 0.090 |
Why?
|
Tetralogy of Fallot | 1 | 2016 | 631 | 0.090 |
Why?
|
Physical Examination | 1 | 2017 | 1254 | 0.090 |
Why?
|
Sleep Deprivation | 1 | 2017 | 843 | 0.090 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2013 | 492 | 0.090 |
Why?
|
Monitoring, Physiologic | 1 | 2018 | 1780 | 0.090 |
Why?
|
Prevalence | 4 | 2022 | 15717 | 0.090 |
Why?
|
ADAM Proteins | 1 | 2011 | 238 | 0.090 |
Why?
|
England | 1 | 2011 | 527 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 3 | 2024 | 17912 | 0.080 |
Why?
|
Tissue Engineering | 1 | 2019 | 1867 | 0.080 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2734 | 0.080 |
Why?
|
Premedication | 1 | 2009 | 247 | 0.080 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2010 | 344 | 0.080 |
Why?
|
Radiography, Interventional | 2 | 2013 | 1121 | 0.070 |
Why?
|
Prognosis | 4 | 2024 | 29620 | 0.070 |
Why?
|
Social Perception | 1 | 2011 | 433 | 0.070 |
Why?
|
Atrial Function, Right | 1 | 2007 | 32 | 0.070 |
Why?
|
Atrial Flutter | 1 | 2009 | 252 | 0.070 |
Why?
|
Sequence Deletion | 1 | 2011 | 1494 | 0.070 |
Why?
|
RNA Splicing | 1 | 2012 | 918 | 0.070 |
Why?
|
Middle Aged | 21 | 2024 | 220826 | 0.070 |
Why?
|
Risk Assessment | 8 | 2024 | 23990 | 0.070 |
Why?
|
Primary Prevention | 1 | 2014 | 1186 | 0.070 |
Why?
|
Skin | 1 | 2020 | 4481 | 0.070 |
Why?
|
Vena Cava, Superior | 1 | 2007 | 198 | 0.070 |
Why?
|
Abnormalities, Multiple | 1 | 2013 | 1424 | 0.060 |
Why?
|
Comprehension | 1 | 2011 | 621 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2019 | 4936 | 0.060 |
Why?
|
Boston | 5 | 2018 | 9330 | 0.060 |
Why?
|
Amiodarone | 1 | 2007 | 216 | 0.060 |
Why?
|
Choice Behavior | 1 | 2011 | 824 | 0.060 |
Why?
|
Atrial Function, Left | 1 | 2006 | 185 | 0.060 |
Why?
|
Radiation Dosage | 1 | 2013 | 1958 | 0.060 |
Why?
|
Electrodes | 1 | 2007 | 615 | 0.060 |
Why?
|
Cryosurgery | 1 | 2009 | 474 | 0.060 |
Why?
|
Anticoagulants | 2 | 2010 | 4813 | 0.060 |
Why?
|
Pulmonary Circulation | 1 | 2007 | 743 | 0.060 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2005 | 352 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3639 | 0.060 |
Why?
|
Pressure | 1 | 2007 | 1155 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3905 | 0.060 |
Why?
|
Pattern Recognition, Automated | 1 | 2009 | 997 | 0.050 |
Why?
|
Heart Murmurs | 1 | 2003 | 93 | 0.050 |
Why?
|
Skin Diseases | 1 | 2011 | 1093 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2015 | 15838 | 0.050 |
Why?
|
Incidence | 2 | 2020 | 21341 | 0.050 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2003 | 108 | 0.050 |
Why?
|
Postoperative Period | 1 | 2007 | 1815 | 0.050 |
Why?
|
Pregnancy | 3 | 2020 | 29862 | 0.050 |
Why?
|
Pacemaker, Artificial | 2 | 2021 | 808 | 0.050 |
Why?
|
Organ Size | 1 | 2007 | 2254 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10766 | 0.050 |
Why?
|
Models, Cardiovascular | 1 | 2007 | 981 | 0.050 |
Why?
|
Ventricular Function, Left | 2 | 2024 | 3879 | 0.050 |
Why?
|
Drug Resistance | 1 | 2007 | 1595 | 0.050 |
Why?
|
Europe | 2 | 2018 | 3423 | 0.040 |
Why?
|
Algorithms | 2 | 2011 | 14026 | 0.040 |
Why?
|
Recovery of Function | 1 | 2010 | 2977 | 0.040 |
Why?
|
Telemetry | 1 | 2020 | 199 | 0.040 |
Why?
|
Genetic Counseling | 1 | 2022 | 627 | 0.040 |
Why?
|
Pediatrics | 1 | 2013 | 3595 | 0.040 |
Why?
|
Survival Rate | 3 | 2020 | 12720 | 0.040 |
Why?
|
Infant, Newborn, Diseases | 1 | 2003 | 591 | 0.040 |
Why?
|
Prospective Studies | 8 | 2024 | 54415 | 0.040 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2018 | 144 | 0.040 |
Why?
|
Arteries | 1 | 2022 | 1124 | 0.040 |
Why?
|
Pedigree | 2 | 2017 | 4589 | 0.030 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2011 | 2422 | 0.030 |
Why?
|
Adipogenesis | 1 | 2019 | 368 | 0.030 |
Why?
|
Disclosure | 1 | 2022 | 748 | 0.030 |
Why?
|
Protein Isoforms | 2 | 2012 | 1699 | 0.030 |
Why?
|
Fluoroscopy | 2 | 2013 | 947 | 0.030 |
Why?
|
Device Removal | 1 | 2021 | 630 | 0.030 |
Why?
|
United States | 4 | 2020 | 72339 | 0.030 |
Why?
|
Patient Selection | 3 | 2017 | 4244 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 587 | 0.030 |
Why?
|
Morbidity | 1 | 2020 | 1750 | 0.030 |
Why?
|
Adenoviridae | 1 | 2019 | 1084 | 0.030 |
Why?
|
Autistic Disorder | 1 | 2024 | 1220 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2007 | 8529 | 0.030 |
Why?
|
Observer Variation | 2 | 2011 | 2605 | 0.030 |
Why?
|
Postoperative Care | 1 | 2020 | 1471 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2019 | 2677 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2019 | 18964 | 0.030 |
Why?
|
Professional-Family Relations | 1 | 2017 | 495 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2006 | 20556 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2024 | 18247 | 0.030 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 1993 | 2199 | 0.030 |
Why?
|
Fibrosis | 1 | 2019 | 2048 | 0.030 |
Why?
|
Cell Line | 2 | 2019 | 15605 | 0.020 |
Why?
|
Equipment Failure | 1 | 2014 | 578 | 0.020 |
Why?
|
Reproducibility of Results | 4 | 2013 | 20093 | 0.020 |
Why?
|
Punctures | 1 | 2013 | 366 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 2019 | 1272 | 0.020 |
Why?
|
London | 1 | 2010 | 234 | 0.020 |
Why?
|
Genotype | 1 | 2024 | 13009 | 0.020 |
Why?
|
Expressed Sequence Tags | 1 | 2010 | 250 | 0.020 |
Why?
|
Liver | 1 | 2005 | 7532 | 0.020 |
Why?
|
AIDS-Related Complex | 1 | 1989 | 107 | 0.020 |
Why?
|
International Cooperation | 1 | 2016 | 1422 | 0.020 |
Why?
|
RNA Splice Sites | 1 | 2010 | 211 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2010 | 1058 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2024 | 14409 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2898 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2013 | 15650 | 0.020 |
Why?
|
Gestational Age | 1 | 2018 | 3576 | 0.020 |
Why?
|
International Normalized Ratio | 1 | 2010 | 382 | 0.020 |
Why?
|
beta 2-Microglobulin | 1 | 1989 | 329 | 0.020 |
Why?
|
Syndrome | 1 | 2014 | 3268 | 0.020 |
Why?
|
Aging | 1 | 2007 | 8705 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2014 | 2115 | 0.020 |
Why?
|
Zidovudine | 1 | 1989 | 624 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 2010 | 5492 | 0.020 |
Why?
|
Aged | 5 | 2024 | 169235 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2011 | 1834 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2010 | 1992 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4741 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9535 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6422 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14664 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2010 | 1612 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2012 | 3087 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2016 | 22168 | 0.020 |
Why?
|
Tachycardia, Ectopic Atrial | 1 | 2005 | 65 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2010 | 1093 | 0.020 |
Why?
|
Animals | 3 | 2024 | 168441 | 0.020 |
Why?
|
Mice | 2 | 2024 | 81509 | 0.020 |
Why?
|
Systems Integration | 1 | 2006 | 426 | 0.010 |
Why?
|
Hospital Costs | 1 | 2010 | 948 | 0.010 |
Why?
|
Genome, Human | 1 | 2017 | 4425 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3418 | 0.010 |
Why?
|
DNA | 1 | 2018 | 7219 | 0.010 |
Why?
|
Myocarditis | 1 | 2011 | 787 | 0.010 |
Why?
|
MicroRNAs | 1 | 2019 | 3812 | 0.010 |
Why?
|
Apoptosis | 1 | 2019 | 9488 | 0.010 |
Why?
|
Communication | 1 | 2017 | 3871 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2009 | 2358 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4575 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4852 | 0.010 |
Why?
|
Drug Costs | 1 | 2010 | 1183 | 0.010 |
Why?
|
Adenosine | 1 | 2006 | 808 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3428 | 0.010 |
Why?
|
Ultrasonography | 1 | 2013 | 5970 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12456 | 0.010 |
Why?
|
User-Computer Interface | 1 | 2006 | 1400 | 0.010 |
Why?
|
Transcription Factors | 1 | 2019 | 12125 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10762 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2013 | 5291 | 0.010 |
Why?
|
Base Sequence | 1 | 2010 | 12450 | 0.010 |
Why?
|
Hemorrhage | 1 | 2010 | 3425 | 0.010 |
Why?
|
Comorbidity | 1 | 2013 | 10498 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15941 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2005 | 36423 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 17644 | 0.010 |
Why?
|
Myocardium | 1 | 2010 | 4725 | 0.010 |
Why?
|
Research Design | 1 | 1993 | 6178 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 1993 | 8000 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2011 | 12330 | 0.010 |
Why?
|
Radiography | 1 | 2007 | 6966 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 26112 | 0.010 |
Why?
|
Health Care Costs | 1 | 2009 | 3243 | 0.010 |
Why?
|
Reoperation | 1 | 2005 | 4303 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2005 | 5246 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9418 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2010 | 16979 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 11902 | 0.010 |
Why?
|
Research Subjects | 1 | 1993 | 249 | 0.010 |
Why?
|
Cohort Studies | 1 | 2013 | 41446 | 0.010 |
Why?
|
Retroviridae Proteins | 1 | 1989 | 94 | 0.010 |
Why?
|
HIV Core Protein p24 | 1 | 1989 | 245 | 0.010 |
Why?
|
HIV Antigens | 1 | 1989 | 325 | 0.000 |
Why?
|
Pregnant Women | 1 | 1993 | 566 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11118 | 0.000 |
Why?
|
Leukocyte Count | 1 | 1989 | 1596 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2009 | 58956 | 0.000 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1989 | 4370 | 0.000 |
Why?
|